Personalized Prescribing
A More Targeted Treatment of Mental Illness

There have been numerous discussions regarding mental illness over the years. Yet its diagnosis and treatment typically rely on trial and error methods. Personalized Prescribing challenges this status quo with a focus on genetic testing.

Personalized Prescribing has designed the most comprehensive pharmacogenetic testing services that identify the most compatible antidepressant for a person. The test also helps doctors by identifying the most likely dysregulated neurotransmitter pathway of their patients. It tests patients' genetic brain receptors, liver enzymes for appropriate drug clearance, and the blood-brain barrier protein to determine if they are compatible with a specific kind of drug. This plays a vital role in determining more targeted and effective treatment options.

“Prescribing psychotropic drugs is difficult for psychiatrists due to the lack of proper diagnostic tools. This is why the drug failure rate is extremely high, causing significant harm to patients,” says Mark Faiz, CEO of Personalized Prescribing.

The company’s testing services are beneficial for bringing workers back to work who suffer from a mental illness-associated disability. As a result, almost half of the insurance companies in Canada that deal with employee disability insurance rely on Personalized Prescribing for faster and better treatment of the patients.

Typically, when employees face some mental health condition, they visit their physician and start taking the prescribed medicines. In most cases, this medication does not bring optimum outcomes, leading to disability claims. Consequently, the insurance company becomes responsible for paying the employee, which is a significant monetary burden. To mitigate this financial loss, insurance companies seek Personalized Prescribing’s help. The company ensures patients are equipped with the right medication recommendation. This way, employees with mental health issues can recover and quickly get back to work.

“We conduct genetic tests using patients’ saliva and create the report. Our pharmacists then go through the reports to decipher where the problem lies. In the next step, they create a personalized pharmacogenomic report, Rx Report, and share it with physicians, giving them the most suitable recommendations regarding medication,” says Faiz.

What differentiates Personalized Prescribing is its focus on the brain receptors and the blood-brain barrier. The company’s proprietary testing technology allows it to determine the right medication that is compatible with the brain receptor drug targets and is allowed by the blood-brain barrier.

To further up its ante, the company is planning to work directly with employers to ensure their employees are on the most appropriate antidepressants as early as possible to avoid aggravating their mental illness.

Personalized Prescribing is truly revolutionizing, contributing, and defining its path in the field of mental illness diagnosis and treatment